These findings suggest that dietary glutamine restriction activates the GCN2 signaling pathway and downstream ATF4 and ASCT2 expression, leading to an elevated glutamine uptake rate that sustains cancer cells. This evidence concerns the gene EIF2AK4 and cancer.